Controlled release of interleukin-2 for tumour immunotherapy using alginate/chitosan porous microspheres

Porous microspheres were formed by the gelation of two polysaccharides, a polyanionic sodium alginate and a polycationic chitosan, followed by lyophilization which creates the porous structure. Porous microspheres were also formed by gelation of sodium alginate with CaCl 2 and gelation of sodium alg...

Full description

Saved in:
Bibliographic Details
Published inJournal of controlled release Vol. 43; no. 1; pp. 65 - 74
Main Authors Liu, Lin-Shu, Liu, Shu-Qin, Ng, Steven Y, Froix, Michael, Ohno, Tadao, Heller, Jorge
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 03.01.1997
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Porous microspheres were formed by the gelation of two polysaccharides, a polyanionic sodium alginate and a polycationic chitosan, followed by lyophilization which creates the porous structure. Porous microspheres were also formed by gelation of sodium alginate with CaCl 2 and gelation of sodium alginate with polylysine. FITC-BSA was incorporated into the microspheres by mixing the protein with the polysaccharide solution prior to gelation. Interleukin-2 (IL-2) was incorporated into the preformed microspheres by diffusion from an external aqueous solution of IL-2. Sustained release of the proteins from porous alginate/chitosan microspheres is of longer duration than from alginate/CaCl 2, or from alginate/polylysine microspheres. Activity of the released IL-2 was investigated by determining the induction of cytotoxic T lymphocytes (CTL) when incubated with tumor cells and lymphocytes. It was found that the IL-2 remained active in the alginate/chitosan microspheres since the released IL-2 triggered induction of CTL. Further, IL-2 released in a sustained manner triggered induction of CTL more efficiently than free IL-2. Tumor-killing specific activity of CTL was the same whether induced by the sustained released IL-2 or by the addition of free IL-2.
ISSN:0168-3659
1873-4995
DOI:10.1016/S0168-3659(96)01471-X